Search Results 721-730 of 16292 for Break STD Taboo

  1. Breast cancer - Doctors and departments - Mayo Clinic

    ... standard approach. And I think that is one of the unique characteristics of Mayo's approach to research — that patient-centeredness — that really helps to ...

  2. Avatrombopag for the Treatment of Thrombocytopenia in Adults Scheduled for a Surgical Procedure - Mayo Clinic

    ... standard therapy. They also compare the safety of the new treatment with that of current treatments. Phase 3 trials include large numbers of people to make ...

  3. Breast cancer - Doctors and departments - Mayo Clinic

    ... standard approach. And I think that is one of the unique characteristics of Mayo's approach to research — that patient-centeredness — that really helps to ...

  4. Breast cancer - Doctors and departments - Mayo Clinic

    ... standard approach. And I think that is one of the unique characteristics of Mayo's approach to research — that patient-centeredness — that really helps to ...

  5. Publications - Bo E. Madsen, M.D., M.P.H. - Mayo Clinic

    ... standard note in the emergency department. Am J Emerg Med. 2023 Jan; 63:79-85 Epub 2022 Oct 13. View PubMed; Nelson DM, Madsen BE, Kopecky SL, Jenson CE, Loth ...

  6. Clinical trials - Oncology (Medical)

    The secondary goal is to asses clinical endopoints associated with standard of care therapies for TCR MM, in a real-world setting during 12 months of ...

  7. Safety Study of Mocetinostat in Combination With Azacitidine in Subjects With MDS - Mayo Clinic

    ... standard therapy. They also compare the safety of the new treatment with that of current treatments. Phase 3 trials include large numbers of people to make ...

  8. Comparison of Combination Chemotherapy Regimens in Treating Older Women Who Have Undergone Surgery for Breast Cancer - Mayo Clinic

    Adjuvant chemotherapy for older adults with breast cancer: making the standard a standard. Pal SK. Sumanta Kumar; Mortimer J. Joanne. Women's health (London ...

  9. Efficacy, Safety, and Tolerability of Oral Full-Spectrum Microbiota® (CP101) in Subjects with Recurrence of Clostridium difficile Infection (PRISM3) - Mayo Clinic

    ... standard therapy. They also compare the safety of the new treatment with that of current treatments. Phase 3 trials include large numbers of people to make ...

  10. Efficacy, Safety and Pharmacokinetics of Topical Timolol in Infants With Infantile Hemangioma (IH) - Mayo Clinic

    ... standard therapy. They also compare the safety of the new treatment with that of current treatments. Phase 3 trials include large numbers of people to make ...